Oishi T - Search Results

1

Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging.

Shimada M, Kigawa J, Kanamori Y, Itamochi H, Oishi T, Minagawa Y, Ishihara K, Takeuchi Y, Okada M, Terakawa N. Shimada M, et al. Among authors: oishi t. Int J Gynecol Cancer. 2005 Jul-Aug;15(4):601-5. doi: 10.1111/j.1525-1438.2005.00115.x. Int J Gynecol Cancer. 2005. PMID: 16014112 Free article. Clinical Trial.

2

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.

Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Cheng X, Okada M, Oishi T, Terakawa N. Kigawa J, et al. Among authors: oishi t. Cancer. 1998 Feb 15;82(4):697-702. doi: 10.1002/(sici)1097-0142(19980215)82:4<697::aid-cncr12>3.0.co;2-t. Cancer. 1998. PMID: 9477102

3

Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.

Oishi T, Kigawa J, Minagawa Y, Shimada M, Takahashi M, Terakawa N. Oishi T, et al. Obstet Gynecol. 1998 Apr;91(4):568-71. doi: 10.1016/s0029-7844(98)00044-1. Obstet Gynecol. 1998. PMID: 9540942

4

Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.

Okada M, Kigawa J, Minagawa Y, Kanamori Y, Shimada M, Takahashi M, Oishi T, Terakawa N. Okada M, et al. Among authors: oishi t. Gynecol Oncol. 1998 Jul;70(1):61-4. doi: 10.1006/gyno.1998.5005. Gynecol Oncol. 1998. PMID: 9698475 Clinical Trial.

5

Residual disease and presence of human papillomavirus after conization.

Kanamori Y, Kigawa J, Minagawa Y, Irie T, Oishi T, Itamochi H, Cheng X, Terakawa N. Kanamori Y, et al. Among authors: oishi t. Oncology. 1998 Nov-Dec;55(6):517-20. doi: 10.1159/000011905. Oncology. 1998. PMID: 9778616

6

A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells.

Kanamori Y, Kigawa J, Minagawa Y, Irie T, Oishi T, Shimada M, Takahashi M, Nakamura T, Sato K, Terakawa N. Kanamori Y, et al. Among authors: oishi t. Eur J Cancer. 1998 Oct;34(11):1802-6. doi: 10.1016/s0959-8049(98)00199-3. Eur J Cancer. 1998. PMID: 9893672

7

Topoisomerase-I activity and response to second-line chemotherapy consisting of camptothecin-11 and cisplatin in patients with ovarian cancer.

Kigawa J, Takahashi M, Minagawa Y, Oishi T, Sugiyama T, Yakushiji M, Terakawa N. Kigawa J, et al. Among authors: oishi t. Int J Cancer. 1999 Oct 22;84(5):521-4. doi: 10.1002/(sici)1097-0215(19991022)84:5<521::aid-ijc13>3.0.co;2-x. Int J Cancer. 1999. PMID: 10502731

8

Alteration of telomerase activity in ovarian cancer after chemotherapy.

Takahashi M, Kigawa J, Oishi T, Itamochi H, Shimada M, Sato S, Kamazawa S, Akeshima R, Terakawa N. Takahashi M, et al. Among authors: oishi t. Gynecol Obstet Invest. 2000;49(3):204-8. doi: 10.1159/000010247. Gynecol Obstet Invest. 2000. PMID: 10729763

9

Alteration of a p53 gene status affects outcome of patients with recurrent ovarian cancer.

Irie T, Kigawa J, Minagawa Y, Oishi T, Takahashi M, Shimada M, Kamazawa S, Sato S, Terakawa N. Irie T, et al. Among authors: oishi t. Oncology. 2000 Apr;58(3):237-41. doi: 10.1159/000012106. Oncology. 2000. PMID: 10765126

10

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.

Akeshima R, Kigawa J, Takahashi M, Oishi T, Kanamori Y, Itamochi H, Shimada M, Kamazawa S, Sato S, Terakawa N. Akeshima R, et al. Among authors: oishi t. Br J Cancer. 2001 Jun 1;84(11):1551-5. doi: 10.1054/bjoc.2001.1812. Br J Cancer. 2001. PMID: 11384107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

825 results

Search Page

Filters